MiniMed Insulin Pump

Find a Lawyer in Your State

Need Help?

Contact Us Today

Call Today: (800) 653-9958

I agree that submitting this form and the information contained within does not establish an attorney client relationship.

ATTORNEY ADVERTISING -
Flood Law Group, LLP
1101 Pennsylvania Avenue
Suite 600
Washington, DC 20004
(888) 334-2084

Privacy protected. All information held in the strictest confidence.

MiniMed Paradigm Reservoirs

MiniMed Paradigm reservoirs are the hollow spaces in Medtronic MiniMed insulin pumps that contain the fast-acting insulin continuously delivered to diabetes patients. First introduced by Medtronic in 1983, the Paradigm MiniMed insulin pumps – when worn 24 hours/day, 7 days/week – help individuals better manage their diabetes because they:

Alter the flow of insulin delivered to patients based on the individual's changing blood sugar levels
Administer more precise amounts of insulin (versus syringes)
Allow patients to vary their rigid eating and exercise schedules

The amount of insulin held by a particular pump's reservoir will depend on the model of the pump: While Paradigm MiniMed Pump 522 only holds 1.76 ml of insulin, Medtronic Insulin Pump 722 can hold up to 3 ml (300 units) of insulin.

Larger MiniMed Paradigm reservoirs are recommended for those who are or are expecting to:

need more than 50 ml of insulin daily
become pregnant
go through adolescence
undergo any other significant physical changes

Warning About MiniMed Paradigm Reservoirs

Diabetes patients who use Medtronic MiniMed insulin pumps should regularly check the reservoirs of these devices to ensure that they always contain a sufficient amount of insulin. Should an insulin pump reservoir be empty for extended periods of time, patients will not receive adequate amounts of insulin and, in turn, run the risk of developing hyperglycemia, a potentially fatal condition marked by acutely low blood glucose levels.

Without the proper treatment, hyperglycemia can cause blindness, heart disease and – in the most dire cases – death.

Medtronic Recalls Insulin Pump Therapy Systems

In July 2009, Medtronic announced that it was going to voluntarily recall one lot (Lot 8) of the MiniMed insulin pump systems, including the associated Quick-set infusion sets. As a vital part of insulin pump therapy systems, infusion sets are the disposable medical supplies that implant a small tube, known as the cannula, beneath the skin. Insulin is delivered through the cannula to the patient.

Medtronic issued this nationwide, Class I recall because it suspected that around 60,000 infusion sets were defective. Three million systems are included in the recall. Recalled numbers include:

MMT-359S6
MMT-359S9
MMT-359L6
MMT-359L9

Lot 8 Quick Set Infusion Sets were distributed throughout the U.S. and in small batches in the following countries: Bahamas, Bermuda, Brazil, Canada, Ecuador, El Salvador, Germany, Kuwait, Mexico, Paraguay, Turkey and the UK.

Serious Injuries Linked to “Lot 8” Quick-Set Infusion Sets

Over 200 hospitalizations have occurred as a result of defective MiniMed insulin pump systems. In most cases, patients:

were not receiving enough insulin
suffered severe hyperglycemia
reported that the defects in their device stemmed around bent or disconnected cannulas

Diabetes patients injured after using defective Medtronic MiniMed insulin pumps will likely be entitled to a settlement by pursuing a defective device lawsuit.

If you or a loved one has been injured or killed after using one of the defective insulin pumps, you can find out about your legal rights by contacting our MiniMed Insulin Pump Lawyers.

Our injury and death lawyers are investigating all MiniMed cases. Our evaluations are not limited to persons injured by the recalled "Lot 8" infusion sets. To discuss the details of your unique circumstances, please contact our law offices today.

Online Lawyer Source

Lawyers & Legal News Near You

Need Legal Help?

Start Here for a Free Case Review!